Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
US9403822B2 · kind B2 · utility
7Cited by
19References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 2015 |
| Grant date | Aug 2, 2016 |
| Priority date | — |
| Expiry date | Mar 11, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.